Bacterial resistance in acne

Dermatology : International Journal for Clinical and Investigative Dermatology
E A Eady

Abstract

Antibiotics play a major role in acne therapy. Physicians base treatment choices on personal perceptions of efficacy, cost-effectiveness or risk-benefit ratios and rarely take bacterial resistance into account. It is well documented that resistant strains of coagulase-negative staphylococci within the resident skin flora increase in both prevalence and population density as duration of therapy increases. Acne patients represent a considerable reservoir of resistant strains of these important nosocomial pathogens which can be transferred to close contacts. Resistance in cutaneous propionibacteria has received scant attention in view of the central role of Propionibacterium acnes in inflammatory acne. Isolates resistant to one or more anti-acne antibiotics (most commonly erythromycin) have been reported in Europe, the USA, Japan and New Zealand. Carriage of resistant strains results in therapeutic failure of some but not all antibiotic regimens. In our region, skin carriage of resistant strains by 60% of acne patients and 1 in 2 of their close contacts suggests that resistant strains are widely disseminated. We are beginning to gain an understanding of those factors which encourage resistance development and can identify those pa...Continue Reading

Citations

Sep 5, 2002·Lasers in Surgery and Medicine·Dilip Y PaithankarBradley S Graham
Oct 4, 2005·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·C BorelliK Degitz
Oct 6, 2005·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·A Thielitz, H Gollnick
Aug 16, 2000·Pediatric Clinics of North America·D P Krowchuk
Jan 5, 2002·Diagnostic Microbiology and Infectious Disease·M A PfallerUNKNOWN MYSTIC Program Study Group
Jan 5, 2002·Diagnostic Microbiology and Infectious Disease·H Goossens, UNKNOWN MYSTIC Study Group (Europe)
Dec 21, 2002·Diagnostic Microbiology and Infectious Disease·Helio S SaderUNKNOWN SENTRY Participants Group (Latin America)
Mar 1, 2003·Clinics in Dermatology·Noah S ScheinfeldJeffrey M Weinberg
Feb 19, 2003·FEMS Immunology and Medical Microbiology·Helena AshkenaziYeshayahu Nitzan
Oct 26, 2000·Current Opinion in Microbiology·S Monroe, R Polk
Oct 6, 1999·Current Opinion in Microbiology·D Guillemot
Aug 29, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P Courvalin, P Trieu-Cuot
Jul 20, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D GuillemotUNKNOWN French Working Party to Promote Research to Control Bacterial Resistance
Oct 13, 2006·Current Opinion in Infectious Diseases·E Ingham
Mar 28, 2007·Antimicrobial Agents and Chemotherapy·Stefanie HellerStuart Shapiro
Aug 31, 2002·BMJ : British Medical Journal·Guy F Webster
Dec 14, 2002·BMJ : British Medical Journal·Sarah GarnerTony Avery
Jun 19, 2002·American Journal of Clinical Dermatology·Gregory T Warner, Greg L Plosker
Aug 11, 2004·American Journal of Clinical Dermatology·Aikaterini CharakidaAntony C Chu
Nov 11, 2010·American Journal of Clinical Dermatology·Marissa D NewmanAlan R Shalita
May 9, 2008·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Susanne Astner, Sandy S Tsao
Feb 15, 2008·The Journal of Dermatological Treatment·Marc J IngleseRajesh Balkrishnan
Oct 27, 2005·The Journal of Dermatological Treatment·Suganthi ThevarajahAlan B Fleischer
Apr 16, 2015·International Journal of Molecular Medicine·Jung-Yeon KimKwan-Kyu Park
Feb 6, 2013·International Journal of Pharmaceutics·Chwan-Fwu LinJia-You Fang
Nov 29, 2011·Dermatologic Clinics·Siri Knutsen-LarsonRobert P Dellavalle
May 7, 2002·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·D Guillemot
Apr 25, 2009·Journal of the American Academy of Dermatology·Diane ThiboutotUNKNOWN Global Alliance to Improve Outcomes in Acne
Apr 14, 2007·Dermatologic Clinics·James Q Del Rosso, James J Leyden
Apr 6, 2005·Clinical and Experimental Dermatology·S KusA Aytug
Nov 13, 2004·Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)·Ludivine PetitGérald E Piérard
Dec 16, 2003·Skinmed·Joseph B Bikowski
Nov 18, 2006·Lasers in Surgery and Medicine·Seung Yoon LeeMi Youn Park

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.